Recent discoveries may lead to prevention and better treatment of rheumatoid arthritis. By looking at a combination of environmental and genetic factors, three researchers uncovered new information for which they were awarded the Crafoord Prize by the Royal Swedish Academy. “Their focused detective work resulted in a hypothesis that the disease arises from the interplay between genetic inheritance and environmental influences,” the Academy said. “This increased knowledge about the disease’s causes hopefully will result in more refined treatments.”
In other research, Dr. C. Michael Stein, the associate chief and fellowship director of Vanderbilt University Medical Center, has made a career exploring the hidden causes of rheumatoid arthritis and the havoc it wreaks upon its victims’ bodies. Dr. Stein’s research examines the inflammation rheumatoid arthritis produces. This inflammation causes subtle effects on the heart. “We believe these effects can be detected early, before any damage has occurred. If this is correct, we may be able to figure out ways to decrease the risk of heart failure in patients with RA.” This research could one day lead to personalized medicine, and even reverse the inflammation process.
Today, those suffering from cartilage deterioration and rheumatoid arthritis can find pain relief with Lakota Rheumatoid Formula. It combines the cartilage building effects of Collagen Type II therapy with the amino acid L-Proline. Proven to work. Those suffering from osteoarthritis often combine the Lakota Rheumatoid Formula with the Lakota Joint Care Formula for positive results.